Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: DAYANG BIOTECH(003017) the Revenue is 280.76 M (+12.15%);the EBIT is 29.97 M (-0.49%);the EPS is 0.265 (+22.07%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.28B12.15%
----
----
EBIT
0.03B0.49%
----
----
EPS
0.26522.07%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf